BackIdera Pharmaceuticals Overview

Idera Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for IDRA.

Quarterly EBIT

-$22.33M
↓ 434.73% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$47.62M
↓ 118.28% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin